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Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal
hippocampus
Jennifer L. Szczytkowski, Christina Lebonville, Lee Hutson, Rita A.Fuchs, Donald T. Lysle
Abstract

Opioid-associated environmental stimuli elicit robust immune-altering effects via stimulation of
a neural circuitry that includes the basolateral amygdala and nucleus accumbens. These brain
regions are known to have both direct and indirect connections with the hippocampus. Thus, the
present study evaluated whether the dorsal hippocampus (DH), and more specifically interleukin1 beta (IL-1β) within the DH, is necessary for the expression of heroin-induced conditioned
immunomodulation. Rats received five Pavlovian pairings of systemic heroin administration (1.0
mg/kg, SC) with placement into a distinct environment (conditioned stimulus, CS). Six days after
conditioning, a GABAA/B agonist cocktail or IL-1β small interfering RNA (siRNA) was
microinfused into the DH to inhibit neuronal activity or IL-1β gene expression prior to CS or
home cage exposure. Control animals received saline or negative control siRNA microinfusions.
Furthermore, all rats received systemic administration of lipopolysaccharide (LPS) to stimulate
proinflammatory nitric oxide production. CS exposure suppressed LPS-induced nitric oxide
production relative to home cage exposure. Inactivation of, or IL-1β silencing in, the DH
disrupted the CS-induced suppression of nitric oxide production relative to vehicle or negative
control siRNA treatment. These results are the first to show a role for DH IL-1β expression in
heroin-conditioned suppression of a proinflammatory immune response.
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1. Introduction

Opioids exert a number of detrimental physiological effects, including disruption of immune
system functioning, that diminish host defense mechanisms and increase susceptibility to
infectious disease states (Simonovska et al., 2011). For instance, acute heroin administration
results in the suppression of the peripheral proinflammatory mediator inducible nitric oxide
synthase (iNOS), the enzyme that is responsible for nitric oxide production (Lysle and How,
2000). Nitric oxide production by immune cells, particularly macrophages, alters the course of
microbial resistance and autoimmune diseases (Breitbach et al., 2006, Choi et al., 2006, Green et
al., 1990, Green et al., 1993, MacMicking et al., 1995, Murray and Nathan, 1999, Oates and
Gilkeson, 2006, Rossi et al., 1999, Stofkova et al., 2006, Vincendeau et al., 1992, Wei et al.,
1995), provides resistance to viral infections and exerts significant tumor cytotoxicity (Green et
al., 1993, Hibbs et al., 1987, Hrabak et al., 2006, Karupiah et al., 1993). Moreover, mice lacking
the gene for iNOS exhibit increased susceptibility to parasitic and bacterial infections (Lindgren
et al., 2004, Wei et al., 1995), suggesting that iNOS acts as an antimicrobial agent. In addition,
nitric oxide has numerous immunoregulatory functions, including the modulation of cytokine
production (Marcinkiewicz and Chain, 1993, Taylor-Robinson et al., 1994, Van Dervort et al.,
1994) and the suppression of lymphocyte proliferation (Albina and Henry, 1991). Thus, iNOS

plays a critical role in immune function and heroin-induced suppression of nitric oxide likely
increases susceptibility to infection following heroin administration.

Opioid-induced suppression of nitric oxide and other immune parameters are mediated by central
nervous system (CNS) mechanisms. Consistent with this, central administration of the opioid
antagonist, N-methylnaltrexone (a form of naltrexone which does not readily penetrate the
blood–brain barrier), attenuates the immunomodulatory effects of systemic morphine treatment,
whereas peripheral administration of N-methylnaltrexone is ineffective (Fecho et al., 1996, Lysle
et al., 1996). Furthermore, microinjection of morphine directly into the periaqueductal gray, a
brain region rich in opioid receptors, suppresses natural killer (NK) cell cytotoxicity, an effect
that can be blocked by peripheral administration of the opioid antagonist naltrexone (Weber and
Pert, 1989). Interestingly, following repeated pairing with opioids, environmental stimuli can
acquire the ability to induce alterations in immune function similar to those produced by the drug
itself (Coussons-Read et al., 1994a, Coussons-Read et al., 1994b, Coussons et al., 1992, Luecken
and Lysle, 1992, Lysle et al., 1988, Lysle and Ijames, 2002, Szczytkowski et al., 2011,
Szczytkowski and Lysle, 2007, Szczytkowski and Lysle, 2008, Szczytkowski and Lysle, 2010).
These effects are the result of Pavlovian conditioning, and research in our laboratory has
identified the basolateral amygdala (BLA) and the nucleus accumbens (NAC) as two brain
regions necessary for opioid-induced condition immunomodulation (Saurer et al., 2009,
Szczytkowski and Lysle, 2008). In support of this, D1 dopamine receptor antagonism in the BLA
inhibits conditioned decreases in the production of proinflammatory mediators in peripheral
immune tissues (Szczytkowski and Lysle, 2010). More recently, our laboratory has shown that
the integrity of a specific limbic neurocircuitry comprised of the BLA, NAC, and ventral

tegmental area (VTA) is required for heroin-conditioned immunosuppression (Szczytkowski et
al., 2011). Each of these brain regions has anatomical connections with the hippocampus
indicating the possibility that the hippocampus may also play a role in conditioned immune
alterations.

The hippocampus is a heterogeneous structure with compartmentalized functionality and
connectivity. In particular, the dorsal hippocampus (DH) is necessary for declarative, spatial, and
configural learning and memory as well as for “contextual-recall,” a form of memory that is
dependent upon environmental cues (Maren and Holt, 1999, Phillips and Ledoux, 1994, Redish,
2001). Thus, following heroin conditioning, the DH likely provides crucial information about
drug-associated environmental stimuli and facilitates conditioned immunomodulation.
Furthermore, interaction between the BLA and the DH is necessary for the expression of
context-induced drug-seeking behavior (Fuchs et al., 2005). As a regulator of a number of
conditioning processes, the DH appears to be a likely component of the neural circuitry of
heroin-induced conditioned immunomodulation. Accordingly, Experiment 1 in the present study
utilized GABA agonist-induced temporary inactivation of the DH in order to investigate the
hypothesis that the functional integrity of the DH is required for the expression of heroin-induced
conditioned immunosuppression.

The second aim of the present study was to assess the role of the cytokine, interleukin-1 beta (IL1β), in the DH in heroin-induced conditioned immunosuppression. IL-1β is expressed by glia and
neurons in several regions of the brain including the hippocampus (McPherson et al., 2011,
Rothwell, 1991). Once viewed primarily as immune molecules that mediate inflammatory events

during pathology, cytokines are now recognized to be important regulators of neuronal
communication similar in action to neurotransmitters and neuropeptides (Adler et al., 2005).
Surprisingly little is known about brain cytokine function; however, emerging research suggests
that IL-1β is essential for a number of behavioral processes, including learning and memory. For
example, deletion of the IL-1 receptor type 1 (IL-1R1) gene results in impaired hippocampaldependent learning and memory function (Avital et al., 2003, Ben Menachem-Zidon et al., 2011,
Goshen et al., 2007, Schmid et al., 2009). Conversely, Pavlovian fear conditioning is associated
with increased IL-1 gene expression within the hippocampus (Goshen et al., 2007). Together,
these results suggest that optimal levels of IL-1β are required for proper hippocampal function
and memory processing, however, the role of hippocampal IL-1β in conditioned
immunomodulation has not yet been investigated. Thus, Experiment 2 in the present study
utilized small interfering RNA (siRNA) mediated IL-1β RNA interference in order to test the
hypothesis that IL-1β activity in the DH is necessary for the expression of heroin-induced
conditioned immunosuppression.
2. Methods and materials
2.1. Animals

Male Lewis rats (Charles-River Laboratories), weighing 225–250 g, were housed individually in
a colony room under a reversed 12-h day-night cycle, with free access to food and water.
Animals received a 2-week habituation period before experimentation and were handled
regularly during this time. All procedures were approved by the Institutional Animal Care and
Use Committee (IACUC) of the University of North Carolina at Chapel Hill and conformed to

the National Research Council’s Guide for the Care and Use of Laboratory Animals (Institute of
Laboratory Animal Resources on Life Sciences).
2.2. Surgical procedures

Animals were anesthetized with a 1.0 ml/kg intraperitoneal injection of 9:1 (vol:vol) ketamine
hydrochloride (100 mg/ml) mixed with xylazine (100 mg/ml) and were placed into the
stereotaxic apparatus. Guide cannula (26-gauge, Plastics One, Roanoke, VA) were directed
bilaterally toward the DH (AP-3.4 mm, ML ± 3.1 mm, DV-2.15 mm, relative to Bregma; 15°
angle laterally; (Paxinos and Watson, 1998). Animals were given two weeks for post-operative
recovery.
2.3. Conditioning procedure

Based on our prior studies (Szczytkowski et al., 2011, Szczytkowski and Lysle, 2010), rats
received five, 60 min conditioning sessions. Each session involved heroin administration
(diacetylmorphine dissolved in 0.9% sterile saline; NIDA Drug Supply System, Bethesda, MD)
immediately followed by placement into a conditioning chamber (BRS/LVE, Laurel, MD, USA;
26.7 × 24.8 × 30.7) that served as the conditioned stimulus (CS). A 1.0 mg/kg subcutaneous dose
of heroin was selected based on prior experiments in our laboratory showing that this dosage
alters LPS-induced iNOS mRNA expression in the spleen (Lysle and How, 2000, Lysle and
Ijames, 2002, Szczytkowski and Lysle, 2007). The conditioning chambers were located in a
room separate from the animal colony and contained a metal grid floor and cedar bedding to
create an environment distinct from the home cage. Six days after conditioning, the rats were reexposed to the conditioning chamber (CS) or remained in their home cages (HC) for 60 min.

Immediately thereafter, rats received a subcutaneous injection of LPS (1 μg/kg; serotype 055:B5,
dissolved in sterile, pyrogen-free saline) to induce in vivo production of nitric oxide. Rats were
sacrificed 6 h later and a sample of spleen and blood were obtained for the analysis of nitric
oxide.

Prior work utilized a number of conditioning control groups to show systematically that the
conditioned effects observed in this paradigm are due to context exposure itself as opposed to
ancillary effects of the conditioning procedure. These control groups included a salineconditioned group that received saline injections paired with placement into the conditioning
chamber and an unpaired heroin-treated group that was conditioned with saline and received
heroin injections outside of the conditioning context (Lysle and Ijames, 2002). To conserve
animals, these negative control groups were not included in the present study.
2.4. Neuronal inactivation

In Experiment 1, rats received bilateral intra-DH microinfusions (0.3 μl/hemisphere infused over
1 min) of saline vehicle or a cocktail of baclofen and muscimol (0.3 nmol and 0.03 nmol,
respectively) 30 min prior to CS or home cage exposure on the test day. This combination of
GABAB and GABAA agonists has been used extensively to transiently disrupt neural activity in
cell bodies within target brain regions, including the DH, without affecting fibers of passage
(Fuchs et al., 2007, Lasseter et al., 2011, Szczytkowski and Lysle, 2008).

Injectors extended 2 mm beyond the tip of the guide cannula and were left in place for 1 min
after the injection to allow for proper diffusion away from the infusion site. Prior experiments

from our laboratory have shown no effect of inactivation of an anatomical control region, the
somatosensory cortex, that is located just dorsal relative to the DH, on drug context-induced
goal-directed behavior (Fuchs et al., 2005, Ramirez et al., 2009).
2.5. IL-1β silencing

For the siRNA experiment (Experiment 2) and verification (Experiment 3), rats received
intracranial microinfusions of negative control or IL-1β siRNA (both 5.6 pmol/0.7
μl/hemisphere) into the DH 48 h prior to the test session in order to maximize IL-1β knockdown
at the time of testing. Following the infusion (0.23 μl/min), injectors were left in place for 5 min.
The procedure utilized three sets of siRNA designed to the rat IL-1β mRNA sequence (NCBI
Accession number: NM_031512.2) using Invitrogen’s BLOCK-iT™ RNAi Express tool
(Invitrogen; Pre-designed Stealth Select siRNA, HPLC purity). The sense sequences of the IL-1β
siRNA were 5′-CCAAAGUGGAGUUUGAGUCUGCACA-3′, 5′UUGUUCAUCUCGAAGCCUGCAGUGC-3′, and 5′ACUGUCCCUGAACUCAACUGUGAAA-3′, with the corresponding antisense sequences 5′UGUGCAGACUCAAACUCCACUUUGG-3′, 5′-GCACUGCAGGCUUCGAGAUGAACAA3′, and 5′-UUUCACAGUUGAGUUCAGGGACAGU-3′, respectively. Multiple siRNA duplexes
were transfected to target different segments of the intended mRNA sequence, thereby
maximizing knock down efficiency (Chao et al., 2011). Additionally, two different sets of
missense negative control siRNA (Invitrogen; Med and Lo GC Negative Controls, HPLC purity)
were used that complemented the GC content of the IL-1β siRNAs. The sense sequences used
were 5’-AGCUACACUAUCGAGCAAUUAACUU-3’, 5’UUCCUCUCCACGCGCAGUACAUUUA-3’ and the corresponding antisense sequences, 5’-

AAGUUAAUUGCUCGAUAGUGUAGCU-3’ and 5’UAAAUGUACUGCGCGUGGAGAGGAA-3’. All siRNA was complexed with jetSI™
(Polyplus Transfection Illkirch, Cat# 403–05), a cationic lipid transfection agent that facilitates
transfection into brain tissue in vivo, according to the manufacturer’s protocol.
2.6. Real-time qRT-PCR

To determine iNOS mRNA expression, real-time qRT-PCR was performed on tissue samples
from the spleen. The spleen was analyzed because immunohistochemical localization of iNOS in
rats exposed to LPS shows the presence of the iNOS enzyme in a number of immune cells found
in the spleen, including macrophages, lymphocytes, and neutrophils (Bandaletova et al., 1993).
Total RNA was extracted using TRI-Reagent (Molecular Research Center, Cincinnati, OH), a
modification of the original method described by Chomczynski and Sacchi (1987). RNA was
quantified spectrophotometrically (GeneQuant II, Pharmacia-Biotech, Piscataway, NJ, USA).
Reverse transcription was performed using Oligo(dT)18 primer and Moloney Murine Leukemia
Virus-Reverse transcriptase following the protocol of the Advantage RT-for-PCR Kit from
Clontech (Palo Alto, CA, USA). Specific products from the PCR reaction were detected with
Universal ProbeLibrary Probes (Roche, Indianapolis, IN). PCR amplifications were performed
using standard protocols, the LightCycler TaqMan Master Real-Time PCR Kit and the
LightCycler II instrument (Roche, Indianapolis, IN). A master mix containing all reaction
components was prepared and then 20 μl of cDNA with master mix was placed in glass capillary
tubes specifically designed for use in the LightCycler II system. Primers and probes for iNOS
were as follows: 5′-TGAGGATTACTTCTTCCAGCTCA-3′ and 5′TGGGTGTCAGAGTCTTGTGC-3′, using probe #25. Primers were synthesized by the Nucleic

Acids Core Facility (Lineberger Cancer Center, UNC-Chapel Hill). Copy numbers were
generated based on an internal standard curve. Amplifications were carried out for 45 cycles and
curves showing fluorescence at each cycle were determined by the computer software (Roche).
Samples were pre-incubated for 10 min at 95 °C to activate the Fast-Start Taq DNA polymerase.
The cycle temperatures were 95 and 60 °C and the cycle times were 10 and 30 s for the
denaturing and annealing/extending, respectively. Fluorescence level was determined at the end
of the extending phase for each cycle of PCR. A final cooling phase was carried out at 40 °C for
30 s. The analysis of the fluorescence in standards and samples over the course of 45 cycles was
used to derive the number of copies of the target molecule in each sample. Additionally,
assessments of housekeeping gene expression, L13A, were made to verify comparable RNA
quality across samples. L13A primers were 5′-CCCTCCACCCTATGACAAGA-3′ and 5′GGTACTTCCACCCGACCTC-3′, with probe #74. The data are expressed as iNOS copies per
10 ng cDNA based on a standard curve using Roche LightCycler software.
2.7. Nitrite/nitrate assay

The nitrite/nitrate concentration in plasma samples was assessed using the Greiss reagent assay
as described previously (Szczytkowski and Lysle, 2007). Briefly, 6 μl of plasma diluted in 44 μl
of dH2O was incubated in the dark for 90 min with 10 μl of nitrate reductase (1.0 U/ml), 20 μl of
0.31 M phosphate buffer (pH 7.5), 10 μl of 0.86 mM NADPH (Sigma) and 10 μl of 0.11 mM
flavin adenine dinucleotide in individual wells of a 96-well plate. Then, 200 ml of Greiss
reagent, consisting of a 1:1 (v/v) solution 1% sulfanilamide in 5.0% phosphoric acid and 0.1%
N-(1-napthyl) ethyl-enedamine dihydrochloride in distilled water, was added to the samples. The
color developed for 10 min at room temperature, after which, the absorbance was determined

using a spectrophotometer set at 550 nm. All reactions were carried out in triplicate. The total
micromolar concentration of nitrite was determined for each sample based on a standard curve.
Recovery of nitrate is greater than 95% using this assay.
2.8. Histology

To confirm proper cannula placement, Alcian blue dye was infused via the cannulae following
euthanasia. Brains were then extracted and post-fixed in a 4% paraformaldehyde solution.
Following fixation, the brains were transferred to 30% sucrose solution for cryoprotection.
Coronal sections (50 μm) were taken and stained with cresyl violet for verification of cannula
placement using light microscopy.
2.9. Verification of siRNA effectiveness

The effectiveness of the intra-DH siRNA manipulation in inhibiting IL-1β expression was
validated in a separate group of rats. These rats received bilateral IL-1β siRNA or negative
control microinfusions into the DH using the infusion parameters as employed in experiment 2,
followed 48 h later by systemic LPS administration (1.0 mg/kg) to induce hippocampal IL-1β
expression. The DH was harvested for real-time qRT-PCR analysis of IL-1β and L13A
(housekeeping gene) expression 4 h after LPS administration, as described previously. Primers
and probes for IL-1β were as follows: 5′-AGCTTCAGGAAGGCAGTGTC-3′ and 5′TCCCACGAGTCACAGAGGA-3′, using probe #5. The data are expressed as IL-1β copies per
10 ng cDNA based on a standard curve using Roche LightCycler software.
2.10. Statistical analysis

Analyses of variance (ANOVAs) or Student’s t-tests were performed on the data sets, when
appropriate. For all experiments, the significance level was set at 0.05. The source of significant
omnibus ANOVA effects was examined using Tukey’s post-hoc test.
3. Results

Experiment 1 investigated the effect of bilateral DH inactivation on the expression of heroininduced conditioned suppression of inducible nitric oxide synthase (iNOS), an important
peripheral proinflammatory mediator, in the spleen (Hibbs et al., 1987, Vincendeau et al., 1992,
Wei et al., 1995). Cannula placements were located bilaterally in the DH (Fig. 1). Rats received
five Pavlovian conditioning trials during which a distinct environment (conditioned stimulus,
CS) was paired with systemic heroin administration. Six days after conditioning, a test session
was conducted during which the rats were re-exposed to the previously heroin-paired
environment (CS Exposed) or remained in their home cages (HC) for 60 min. A
GABAB/GABAA agonist cocktail (muscimol and baclofen, B/M; 0.3/0.03 nmol; 0.3
μl/hemisphere) or saline was microinfused into the DH 30 min prior to the test session.
Lipopolysaccharide (LPS, 1.0 mg/kg, SC) was administered immediately after testing in order to
induce nitric oxide production. Two indices of nitric oxide production, iNOS mRNA expression
in the spleen and nitrite/nitrate levels in blood plasma, were assessed.
Fig. 1. Injection cannula placement in experiment 1 as verified by light microscopy and mapped
onto schematics from the rat brain atlas of Paxinos and Watson (1998). Symbols represent the
most ventral point of injection cannula tracts for each animal that received bilateral vehicle (Sal)
or B/M microinfusions into the DH following exposure to the previously heroin-paired context
(CS) or the home cage (HC). Numbers indicate the distance from bregma in mm. Symbols: CS +

Sal, open squares (□); CS + B/M, filled squares (■); HC + Sal, open circles (○); HC + B/M,
filled circles (●).
GABA agonist-induced neural inactivation of the DH inhibited the heroin-conditioned
suppression of iNOS mRNA in the spleen (Fig. 2A). The omnibus ANOVA revealed a difference
between the four groups in LPS-induced iNOS copies [F(3,17) = 3.68, P < 0.05]. Pair-wise
comparisons indicated that, following intra-DH saline pretreatment, splenic iNOS mRNA
expression was decreased upon exposure to the previously heroin-paired environment relative to
remaining in the home cage (Tukey test, P = 0.028). Importantly, following intra-DH B/M
pretreatment, splenic iNOS mRNA expression did not differ between the CS exposed and the
home cage groups. There was no significant alteration in housekeeping gene (L13A) expression
between the groups (data not shown). Thus, B/M treatment abolished the heroin-induced
conditioned suppression in splenic iNOS mRNA expression.
Fig. 2. Effects of GABA agonist-induced inactivation of the DH on indices of LPS-induced nitric
oxide production. A: splenic iNOS mRNA expression (mean copies per 10 ng cDNA + SEM)
assessed based on a standard curve using Roche LightCycler software, following bilateral intraDH administration of vehicle (Sal) or GABAA/B agonists (B/M; 0.3/0.03 nmol per 0.3
μl/hemisphere) and exposure to the previously heroin-paired context (CS) or the home cage
(HC). B: plasma nitrate/nitrite levels (mean micromolar concentration of nitrate/nitrite + SEM)
as determined by the Greiss reagent assay. (*) Asterisks indicate significant difference relative to
the Sal + HC group (Tukey test, p < 0.05).
GABA agonist-induced neural inactivation of the DH also impaired heroin-induced conditioned
suppression of plasma nitrite/nitrate levels (Fig. 2B). The omnibus ANOVA revealed a
difference between the four groups in plasma nitrite/nitrate levels [F(3,17) = 4.362, P < 0.05].

Pair-wise comparisons indicated that plasma nitrite/nitrate concentration was decreased upon
exposure to the previously heroin-paired environment relative to remaining in the home cage
(Tukey test, P = 0.011), consistent with the iNOS mRNA expression data. Conversely, following
B/M pretreatment, plasma nitrite/nitrate concentration did not differ upon exposure to the CS.
Thus, B/M treatment disrupted the heroin-conditioned reduction in plasma nitrite/nitrate
concentration.

Experiment 2 investigated the role of DH interleukin-1 beta (IL-1β) in heroin-induced
conditioned suppression of peripheral proinflammatory mediators. As in Experiment 1, cannula
placements were located bilaterally within the DH (Fig. 3). The experimental procedures were
the same as in Experiment 1 except that animals received intra-DH microinfusions of negative
control (missense) or IL-1β small interfering RNA (siRNA; both 5.6 pmol/0.7 μl/hemisphere) 48
h prior to exposure to the previously heroin-paired context or the home cage.siRNA-induced IL1β RNA interference in the DH disrupted heroin-conditioned suppression of iNOS in the spleen
(Fig. 4A). The omnibus ANOVA for iNOS copies revealed a difference between the groups
[F(3,19) = 4.95, P < 0.05]. Pair-wise comparisons indicated that, following negative control
pretreatment in the DH, splenic iNOS mRNA copies were decreased upon exposure to the
previously heroin-paired environment compared to remaining in the home cage (Tukey test, P =
0.046). In contrast, following intra-DH IL-1β sense siRNA pretreatment, splenic iNOS mRNA
expression did not differ upon exposure to the CS. There was no significant alteration in
housekeeping gene (L13A) expression in the groups (data not shown). Thus, IL-1β siRNA
pretreatment disrupted the heroin-conditioned reduction in splenic iNOS mRNA expression.

Fig. 3. Injection cannula placement in experiment 2 as verified by light microscopy and mapped
onto schematics from the rat brain atlas of Paxinos and Watson (1998). Symbols represent the
most ventral point of injection cannula tracts for each animal that received bilateral negative
control or IL-1β siRNA following exposure to the previously heroin-paired context (CS) or the
home cage (HC). Numbers indicate the distance from bregma in mm. Symbols: CS + Neg Con,
open squares (□); CS + siRNA, filled squares (■); HC + Neg Con, open circles (○); HC +
siRNA, filled circles (●).
Fig. 4. Effects of IL-1β RNA interference on indices of LPS-induced nitric oxide production. A:
splenic iNOS mRNA expression (mean copies per 10 ng cDNA + SEM) assessed following
bilateral intra-DH administration of negative control or IL-1β siRNA (both 5.6 pmol/0.7
μl/hemisphere) and exposure to the previously heroin-paired context (CS) or the home cage
(HC). B: plasma nitrate/nitrite levels (mean micromolar concentration of nitrate/nitrite + SEM)
as determined by the Greiss reagent assay. (*) Asterisks indicate significant difference relative to
the Saline + HC group (Tukey test, p < 0.05).
IL-1β RNA interference in the DH also inhibited the heroin-induced conditioned suppression of
plasma nitrite/nitrate levels (Fig. 4B). The omnibus ANOVA for plasma nitrite/nitrate levels
revealed a difference between the groups [F(3,19) = 6.07, P < 0.05]. Pair-wise comparisons
indicated that, following negative control pretreatment in the DH, plasma nitrite/nitrate levels
were decreased upon exposure to the previously heroin-paired environment compared to
remaining in the home cage (Tukey test, P = 0.024). In contrast, following intra-DH IL-1β
siRNA pretreatment, plasma nitrite/nitrate concentration did not differ upon exposure to the CS.
Thus, IL-1β siRNA pretreatment disrupted the heroin-conditioned reduction in plasma
nitrite/nitrate levels.

The effectiveness of the intra-DH siRNA manipulation in blocking IL-1β expression in the DH
was validated in a separate group of rats (Fig. 5). These rats received bilateral IL-1β siRNA or
negative control microinfusions into the DH using the infusion parameters employed in
Experiment 2, followed 48 h later by systemic LPS administration to induce hippocampal IL-1β
expression. The DH was harvested for real-time qRT-PCR analysis of IL-1β expression 4 h after
LPS administration. Intra-DH administration of IL-1β siRNA decreased IL-1β copies in the DH
relative to negative control administration [t(6) = 3.516; P < 0.05]. There was no significant
alteration in housekeeping gene (L13A) expression in the groups (data not shown). Thus, intraDH IL-1β siRNA pretreatment blocked the expression of LPS-induced IL-1β in the DH.
Fig. 5. Effects of the IL-1β siRNA manipulation on LPS-induced IL-1β mRNA expression (mean
copies per 10 ng cDNA + SEM). Negative control or IL-1β siRNA (both 5.6 pmol/0.7
μl/hemisphere) was administered into the DH 4 h prior to LPS administration, and DH tissue was
harvested 4 h thereafter. (*) Asterisk indicates a significant difference relative to negative control
(Student’s t-test, p < 0.05).
4. Discussion

In the present study, both global neural inactivation of the dorsal hippocampus (DH) and
interleukin-1 beta (IL-1β) RNA interference within the DH impaired the ability of a heroinpaired environment to suppress splenic iNOS mRNA expression and plasma nitrite/nitrate levels,
thereby rescuing nitric oxide production. Previous reports from our laboratory have elucidated
key brain regions and identified critical neural circuitry necessary for the expression of heroininduced conditioned immunomodulation. The results of the current set of experiments

significantly expand this line of research by revealing the DH as another necessary component of
the neural circuitry mediating heroin-induced conditioned immunomodulation. Furthermore, the
results also reveal that IL-1β-mediated processes within the DH mediate the conditioned
suppression of LPS-induced nitric oxide production.

Nitric oxide is essential for the body’s defense against infectious challenge as its induction is
associated with protection against numerous pathogens, including bacteria, fungi, parasites, and
viruses (Liew, 1994, Tsai et al., 1997). Bacterial infections associated with injection drug use
account for more than one-third of drug-related hospital admissions and can quickly progress to
major systemic infection and cause severe damage to organs such as the heart and lungs
(Orangio et al., 1984, White, 1973). Since heroin use is associated with a high incidence of
opportunistic infections (Hussey and Katz, 1950, Louria et al., 1967, Luttgens, 1949, Theodorou
and Haber, 2005) and both heroin administration and exposure to heroin-associated cues
significantly reduce LPS-induced iNOS expression (Lysle and How, 2000, Lysle and Ijames,
2002), drug-induced and drug-conditioned reductions in nitric oxide production may be involved
in this increased incidence of infectious disease. Thus, the finding that these conditioned
reductions in nitric oxide are mediated by IL-1β signaling in the DH provides an important
public health perspective. While the focus of the current study was on splenic iNOS expression,
it is likely that other immune parameters may also be subject to alteration by inactivation or IL1β suppression within the hippocampus. Previous research from our laboratory has shown that
inactivation of other key brain regions (i.e., the BLA and NAC) attenuates conditioned
immunomodulation across several immune parameters, including peripheral expression of the
cytokines TNF-α, IL-6 and IL-1 (Szczytkowski et al., 2011, Szczytkowski and Lysle, 2008).

The results of Experiment 1 in the present study demonstrate that the functional integrity of the
DH is necessary for conditioned immunomodulation. Temporary inactivation of the DH blocked
heroin conditioned suppression of LPS-induced nitric oxide production. The DH is somewhat
isolated from adjacent brain regions as it is surrounded by the lateral ventricle. Furthermore,
temporary neural inactivation of the dorsally overlying trunk region of the somatosensory cortex,
the brain region most likely in the path of inadvertent B/M infusion away from the DH, fails to
alter drug-induced conditioned behaviors, such as drug context-induced cocaine seeking (Fuchs
et al., 2005). This suggests that the intracranial manipulations in the present study were
anatomically selective to the DH and not due to B/M diffusion to dorsal brain regions.

Previous reports from our laboratory have identified the basolateral amygdala (BLA), nucleus
accumbens (NAC), and ventral tegmental area (VTA) as responsible for mediating conditioned
immunomodulation (Szczytkowski et al., 2011). These brain regions are extensively connected
to one another and to the DH, providing anatomical basis for a putative neural circuitry (DelFava et al., 2007, Ikemoto, 2007, Mcdonald, 1991). In support of this, interaction between the
DH and BLA is necessary for a cocaine-paired context to induce drug-seeking behavior (Fuchs et
al., 2005). Based on its well-known involvement in spatial learning and memory (Fanselow and
Dong, 2010), it is likely that the DH contributes to heroin-induced conditioned
immunomodulation within this circuitry by facilitating the acquisition and expression of
contextual associations.

Immune molecules, such as cytokines, can regulate neural processes including learning and
memory consolidation. IL-1β has been shown to critically mediate hippocampal-dependent
learning via the stimulation of IL-1 receptor type 1 (IL-1R1). IL-1 receptor antagonism disrupts
long-term potentiation (LTP), and mice lacking IL-1β or the IL-1R1 exhibit severe memory
deficits in hippocampal-dependent learning (Ben Menachem-Zidon et al., 2011, Goshen et al.,
2007, Ross et al., 2003, Schneider et al., 1998). However, pathophysiologically high levels of IL1β, such as those observed following infection or injury, are also disruptive to learning and
memory processes and have been associated with cognitive impairment in Alzheimer’s disease
and Down Syndrome (Griffin et al., 1989). In the current study, IL-1β RNA interference in the
DH prevented peripheral immunosuppression by the heroin-paired context. These results show
that, similar to other forms of learning, Pavlovian conditioned immunosuppression requires
optimal levels of IL-1β within the hippocampus and that impaired IL-1 signaling blocks the
expression of the conditioned effect. Additional studies would have to determine whether this
effect is related to interference with memory retrieval processes that are utilized during
reexposure to the CS or block effector processes necessary for peripheral immune modulation.

The cellular effects of IL-1β are cell specific within the hippocampus. Within the DH, several
cell types are capable of producing IL-1β, and both neurons and glia express IL-1 receptors
(Yabuuchi et al., 1994, Zhang et al., 2010). In astrocytes, IL-1β initiates the formation of IL-1β
signaling intermediates, such as interleukin-1 receptor-associated kinase IRAK, (Flannery and
Bowie, 2010, Ringwood and Li, 2008) and the subsequent activation of p38, extracellular signalregulated kinase (ERK) and nuclear factor kappa-light-chain-enhancer of activated B cells
NFkB, (Guasch et al., 2007, Huang et al., 2011). Conversely, in hippocampal neurons, IL-1β

activates p38 and ERK, but not NFkB (Huang et al., 2011). In addition to IRAK-mediated
mechanisms, ERK activation can occur via the IL-1R1-mediated activation of Src family
tyrosine kinases and N-methyl-D-aspartic acid (NMDA) glutamate receptor-mediated signaling
cascades (Bertotto et al., 2011, Davis et al., 2006, Tsakiri et al., 2008, Viviani et al., 2003). Once
activated, ERK and p38 translocate into the nucleus and initiate the transcription of immediateearly genes (e.g., c-Fos, c-Jun) and IL-1β responsive genes and facilitate the stabilization of these
transcripts (Weber et al., 2010, Zhang et al., 2010). Furthermore, NFkB and the mitogenactivated protein kinase, c-Jun N-terminal kinase (JNK), may be important in
immunomodulation via their effects on hypothalamic-pituitary-adrenal (HPA) axis function.
Complex interactions between cell types and multiple signaling cascades likely gives rise to a
nuanced control over immune function by IL-1β. Thus, future studies will need to characterize
the phenotype of DH cells that produce or respond to IL-1β and the IL-1β-mediated intracellular
signaling pathways that control heroin-induced conditioned immunosuppression.

Overall, the results reported here indicate that IL-1β within the DH plays a critical role in heroininduced conditioned immunomodulation. Given that conditioned immunosuppression is a druglike conditioned effect, heroin may also elicit immunosuppression in an IL-1β-dependent
fashion. However, the DH may be uniquely critical for the integration of contextual information
for conditioned, but not for the unconditioned, heroin effects. Future comparisons between the
role of IL-1β in conditioned and unconditioned immunosuppression will therefore enhance our
understanding of each phenomenon. Meanwhile, the results of the present study identify a
mechanism by which nitric oxide, a molecule critical for proper immune functioning, can be
inhibited following exposure to previously heroin-paired environmental stimuli and suggest that

IL-1β may be a target for the development of pharmacotherapies that restore immune function in
former and current opioid users.
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